This is a prototypical case of acute contact dermatitis to benzoyl peroxide that the patient had been applying for her mild to moderate papulo-pustular acne. Twice-daily application of hydrocortisone 2.5% cream led to prompt resolution of the rash.
A 17-year-old girl presented with an “itchy rash” on the cheeks.
Key point: Circumscribed areas of swelling, erythema, oozing, and crusting were seen on both cheeks. The patient, concerned about mild to moderate papulo-pustular acne, began applying an over-the-counter 5% benzoyl peroxide preparation without her parents’ knowledge.
Treatment: Twice-daily application of hydrocortisone 2.5% cream led to prompt resolution of this prototypical case of acute contact dermatitis. The patient was warned to never again use any acne product containing benzoyl peroxide.
Note: Initially, the patient denied applying any topical agents to the face. She admitted to using a medication only when questioned without a parent present in the room.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.